Viva Biotech Holdings (OTCMKTS:VBIZF) Short Interest Up 94.3% in August

Viva Biotech Holdings (OTCMKTS:VBIZF) saw a significant increase in short interest in August. As of August 14th, there was short interest totaling 140,098 shares, an increase of 94.3% from the July 30th total of 72,098 shares. Based on an average trading volume of 1,000 shares, the short-interest ratio is presently 140.1 days.

Viva Biotech Price Performance

OTCMKTS VBIZF opened at $0.19 on Monday. The firm’s fifty day simple moving average is $0.16 and its two-hundred day simple moving average is $0.24. Viva Biotech has a 12-month low of $0.13 and a 12-month high of $0.20.

Viva Biotech Company Profile

Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.

With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.